背景:像ChatGPT这样的大型语言模型(LLM)在诊断医学中的集成,专注于数字病理学,引起了极大的关注。然而,了解在这种情况下与使用LLM相关的挑战和障碍对于成功实施至关重要。
方法:进行了范围审查,以探讨使用LLM的挑战和障碍,专注于数字病理学的诊断医学。利用电子数据库进行了全面检索,包括PubMed和谷歌学者,过去四年发表的相关文章。对选定的文章进行了批判性分析,以识别和总结文献中报告的挑战和障碍。
结果:范围审查确定了与在诊断医学中使用LLM相关的几个挑战和障碍。这些包括上下文理解和可解释性的限制,训练数据中的偏见,伦理考虑,对医疗保健专业人员的影响,以及监管方面的担忧。由于缺乏对医疗概念的真正理解,以及缺乏对受过培训的专业人员选择的医疗记录进行明确培训的这些模型,因此出现了上下文理解和可解释性挑战。andtheblack-boxnatureofLLM.Biasesintrainingdataposesariskofpersistuatingdifferencesandinaccuraciesindiagnoses.伦理考虑包括患者隐私,数据安全,负责任的AI使用。LLM的整合可能会影响医疗保健专业人员的自主性和决策能力。监管方面的担忧围绕着需要指导方针和框架来确保安全和符合道德的实施。
结论:范围审查强调了在诊断医学中使用LLM的挑战和障碍,重点是数字病理学。了解这些挑战对于解决限制和制定克服障碍的策略至关重要。卫生专业人员参与数据的选择和模型的微调至关重要。进一步研究,验证,以及AI开发人员之间的协作,医疗保健专业人员,和监管机构对于确保LLM在诊断医学中的负责任和有效整合是必要的。
BACKGROUND: The integration of large language models (LLMs) like ChatGPT in diagnostic medicine, with a focus on digital pathology, has garnered significant attention. However, understanding the challenges and barriers associated with the use of LLMs in this context is crucial for their successful implementation.
METHODS: A scoping review was conducted to explore the challenges and barriers of using LLMs, in diagnostic medicine with a focus on digital pathology. A comprehensive search was conducted using electronic databases, including PubMed and Google Scholar, for relevant articles published within the past four years. The selected articles were critically analyzed to identify and summarize the challenges and barriers reported in the literature.
RESULTS: The scoping review identified several challenges and barriers associated with the use of LLMs in diagnostic medicine. These included limitations in contextual understanding and interpretability, biases in training data, ethical considerations, impact on healthcare professionals, and regulatory concerns. Contextual understanding and interpretability challenges arise due to the lack of true understanding of medical concepts and lack of these models being explicitly trained on medical records selected by trained professionals, and the black-box nature of LLMs. Biases in training data pose a risk of perpetuating disparities and inaccuracies in diagnoses. Ethical considerations include patient privacy, data security, and responsible AI use. The integration of LLMs may impact healthcare professionals\' autonomy and decision-making abilities. Regulatory concerns surround the need for guidelines and frameworks to ensure safe and ethical implementation.
CONCLUSIONS: The scoping review highlights the challenges and barriers of using LLMs in diagnostic medicine with a focus on digital pathology. Understanding these challenges is essential for addressing the limitations and developing strategies to overcome barriers. It is critical for health professionals to be involved in the selection of data and fine tuning of the models. Further research, validation, and collaboration between AI developers, healthcare professionals, and regulatory bodies are necessary to ensure the responsible and effective integration of LLMs in diagnostic medicine.